Industry top-down
Diagnostics & Research
Latest reported revenue & EPS across the covered companies in this industry, with year-over-year (YoY) change. From disclosed earnings — not investment advice.
AI industry top-down
The Diagnostics and Research industry showed overall moderate growth during FY2026 Q1, recording a median revenue growth rate of 5.4%. While some companies, such as Natera and Adaptive Biotechnologies, achieved high, double-digit revenue growth, major players like Danaher, Illumina, and Charles River experienced revenue declines. Furthermore, many companies showed negative growth in earnings per share (EPS), highlighting a gap between revenue growth and profitability. Overall, the industry presents a complex mix of both growth and contraction.
- Industry revenue growth rate shows a moderate increase of 5.4%
- Some companies recorded double-digit revenue growth
- Negative EPS growth for many companies
- Sluggish revenue and EPS performance for major large companies
AI synthesis of disclosed results and analyst research across these companies — not investment advice.
Companies — latest quarter
| Company | Period | Revenue | Rev YoY | EPS | EPS YoY | Surprise |
|---|---|---|---|---|---|---|
| DHRDANAHER CORP /DE/ | FY2026 Q1 | $5.74B | -0.9% | $1.32 | -9.0% | — |
| NTRANatera, Inc. | FY2026 Q1 | $501.83M | +36.5% | $-0.50 | — | — |
| AAGILENT TECHNOLOGIES, INC. | FY2026 Q1 | $1.68B | +1.4% | $1.11 | -5.9% | — |
| IQVIQVIA HOLDINGS INC. | FY2026 Q1 | $3.83B | +2.5% | $1.40 | -10.3% | — |
| WATWATERS CORP /DE/ | FY2026 Q1 | $662M | +4.0% | $2.03 | +18.0% | — |
| IDXXIDEXX LABORATORIES INC /DE | FY2026 Q1 | $998.43M | +3.6% | $2.96 | +5.3% | — |
| ILMNILLUMINA, INC. | FY2026 Q1 | $1.04B | -3.3% | $0.82 | — | — |
| MTDMETTLER TOLEDO INTERNATIONAL INC/ | FY2026 Q1 | $883.74M | — | $7.81 | — | — |
| DGXQUEST DIAGNOSTICS INC | FY2026 Q1 | $2.65B | +12.1% | $1.94 | +12.8% | — |
| LHLABCORP HOLDINGS INC. | FY2026 Q1 | $3.35B | +5.3% | $2.52 | -6.3% | — |
| GHGuardant Health, Inc. | FY2026 Q1 | $203.47M | +20.8% | $-0.77 | — | — |
| MEDPMedpace Holdings, Inc. | FY2026 Q1 | $558.57M | +9.3% | $3.67 | +14.7% | — |
| CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. | FY2026 Q1 | $984.17M | -2.7% | $0.50 | -61.5% | — |
| ICLRICON PLC | FY2025 Q3 | $1.97B | -67.5% | $1.32 | -72.4% | — |
| BLLNBillionToOne, Inc. | FY2026 Q1 | $58.96M | — | $-0.39 | — | — |
| ADPTAdaptive Biotechnologies Corp | FY2026 Q1 | $52.44M | +25.2% | $-0.20 | — | — |
| GRALGRAIL, Inc. | FY2026 Q1 | $31.84M | +19.1% | $-3.10 | — | — |
| CDNACareDx, Inc. | FY2026 Q1 | $84.69M | +17.5% | $-0.19 | — | — |
| PSNLPersonalis, Inc. | FY2026 Q1 | $20.61M | +5.5% | $-0.18 | — | — |
| OPKOPKO HEALTH, INC. | FY2026 Q1 | $149.95M | — | $-0.10 | — | — |
| CSTLCASTLE BIOSCIENCES INC | FY2026 Q1 | $87.99M | +20.6% | $-0.90 | — | — |
| MYGNMYRIAD GENETICS INC | FY2026 Q1 | $195.9M | -3.1% | $0.00 | — | — |
| BDSXBIODESIX INC | FY2026 Q1 | $17.96M | +21.2% | $-1.52 | — | — |
| 144510GC CELL CORPORATION | FY2026 Q2 | ₩41.6B | -3.1% | ₩157.00 | — | — |
| IMDXInsight Molecular Diagnostics Inc. | FY2026 Q1 | $2.14M | — | $-0.26 | — | — |
| FONRFONAR CORP | FY2023 Q3 | $72.78M | +11.6% | $1.43 | +5.9% | — |
YoY = vs. the same quarter last year · Surprise = EPS actual vs. consensus. Latest reported quarter per company, from disclosed earnings filings. QoQ is omitted because quarterly filings don’t break out Q4 (US) and report cumulatively (KR).